Spectrascience Timeline 2012 through Today All my

New Post Public Reply Private Reply Replies (0) Message Board
joey68
Spectrascience Timeline 2012 through Today

All my opinion..

Looking at a brief overview of the company, we can see that SCIE has made a lot of progress in a relatively short period of time:

Note:
Also notice, when looking at the following PRs in order, its obvious to see how transparent SCIE is with their investors.

2012

May 2012 - WavSTAT Optical Biopsy System Highlighted in Presentations at Digestive Disease Week Conference

July 2012 - SpectraScience to Present at the OneMed Forum /
SpectraScience Reports Estimated Second Quarter Revenue of $310,000

September 2012 - SpectraScience Completes Initial WavSTAT4 Installation and Training With PENTAX Europe

October 2012 - SpectraScience WavSTAT Optical Biopsy System to Be Featured at United European Gastroenterology Week Conference in Amsterdam

November 2012 - SpectraScience to Hold Business Update Conference Call on November 20, 2012

December 2012 - SpectraScience to Present at LD Micro Growth Conference on December 6, 2012

2013

January 2013 - SpectraScience and PENTAX Showcase WaveSTAT4 Optical Biopsy System at Arab Health 2013

April 2013 - SpectraScience Rescheduling Workshops Due to High Demand

Have you read this PR? Its crazy! So much demand, SCIE had to reschedule!

June 2013 - SpectraScience, Inc. Announces Positive Results From Study by Dr. Helmut Neumann / SpectraScience, Inc. Announces Minimum Purchase Agreement With PENTAX Medical / SpectraScience Announces Q2 2013 Revenue $120,000

(Many more PR's would fit here but I'm not taking the time to list them all. Do your DD and youll find them)

2014

April 2014 - SpectraScience Announces SFDA Approval in Saudi Arabia for WavSTAT4

(Many more PR's would fit here but I'm not taking the time to list them all. Do your DD and youll find them)

2015

March 2015 - SpectraScience Announces United Kingdom NHS Technology Alert

May 2015 - SpectraScience Technology Demonstrates Efficacy in Bladder Lesions

November 2015 - SpectraScience and JagWorldwide Enter Into Distribution Agreement

2016

January 2016 - SpectraScience to Display WavSTAT(R) Optical Biopsy System at Arab Health Conference

February 2016 - SpectraScience Acquires Assets of Oncoscope

...and here we are today. The point of this post is that, although it may 'feel' like' or 'appear like' nothing has happened for the past 4 years, we see in the above PRs that a LOT has happened! In fact, I left out the majority of PRs simply because theres too many to list. Think about it. What is one of the number one complaints investors have? At least for me its being invested in a company that never releases PR's, right?

Going to the numbers, since May 2012, Spectrascience has released 37 press releases! In 46 months, we got 37 press releases? And that's not including articles. So technically, 80% of the time we had new press releases to read.

In addition, listing out the press releases like they are above, it shows us the progress SCIE has made. Zacks 2012 said the problem with SCIE wasn't demand. Instead, it was lack of distribution! And ever since that report came out, SCIE got distribution, they went to countless shows and conferences, they pressed their product into trials (many of which are still ongoing), and finally.. after waiting the past 4 years, it feels like we're on the precipice of something major.
So, if youre one of the investors who, like myself, have wondered 'what the heck has SCIE been doing the past 4 years', read the PRs above. All the answers are right there. There are very strict guidelines set from the FDA that SCIE must meet. Remember, the forceps actually goes inside a human body, and someday it may help out one of us. SCIE has to get it right for safety's sake, and seeing they are still going strong, still in business, buying out other companies, doing trials, has PENTAX distribution, has JAG distribution, has FDA approval, has the CE mark... in my opinion, this year is going to be amazing.

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hyundai and Texas Children's Boost Child Safety in Houston

Updated Category News Views 6

A Meaningful Partnership for Safer Houston Roads There's a good feeling about corporations genuinely pitching in for community welfare, and Hyundai teaming up with Texas Children's Hospital to boost child passenger safety around Houston is exactly that. Pairing philanthropy with safety is more than just a business move—it's a testament to human decency. With a $25,000...

Continue Reading
Viedoc and Bioforum Unite: Clinical Data Innovation

Updated Category News Views 19

Revamping Clinical Trials with Data Integration It doesn't take a Wall Street wizard to understand that in today's research game, having data is only half the battle—using it effectively is where the rubber meets the road. Enter Viedoc and Bioforum, two names that are well-acquainted with the grind of the clinical research world. These seasoned pros have joined forces,...

Continue Reading
Torchy's Tacos Reintroduces Nookies: Fan Favorite Returns

Updated Category News Views 34

A Sweet Return to the Menu In the wild world of fast-casual dining, bringing back a beloved menu item is like striking gold. Torchy's Tacos is doing just that by reintroducing their legendary Nookies—fried chocolate chip cookie dough bites that have been a crowd favorite since 2008. After a two-year hiatus, these treats are back, complete with a cinnamon-sugar twist to...

Continue Reading
Static Media Acquires CarScoops to Boost Auto Reach

Updated Category News Views 24

Static Media's Latest Move in the Automotive Arena The digital media landscape keeps morphing, and Static Media just decided to crank up the gears a notch by snapping up CarScoops.com. For those with an eye on the automotive field, it's the kind of play that could shift the tides. Static Media, already a heavyweight with brands like Jalopnik and SlashGear under its belt,...

Continue Reading
Wabi's $1.25B Valuation: A New Era for AI?

Updated Category News Views 71

A Major Milestone for Wabi Well, here we go—Wabi, the brainchild of Eugenia Kuyda, is stirring the pot with a massive $55 million funding round, pulling its valuation up to a hefty $1.25 billion. If you're raising eyebrows at that price tag, you’re not alone. It's a big number riding on an even bigger idea: that AI isn't just for solitary chats anymore, but for...

Continue Reading
Cyclists and Trains: A New Chapter in Urban Travel

Updated Category News Views 23

Rolling Without Engines: LA to SD Picture this: over 75 cyclists and their compact, foldable steeds embarking on a train journey from Los Angeles to the sun-drenched streets of San Diego. In an era where travel is often synonymous with congestion and pollution, this collaboration between Amtrak's Pacific Surfliner and Brompton Bicycle was like a breath of fresh sea air....

Continue Reading
Ascletis' ASC30 Achieves Significant HbA1c Reductions

Updated Category News Views 73

When you dive into the world of biopharma, you never quite know what's going to grab your attention next. Today, it's Ascletis Pharma's (HKEX: 1672) GLP-1 receptor agonist, ASC30, that's piqued my interest. It just wrapped up a U.S. Phase II study with a bang, showing off with some impressive results for type 2 diabetes treatment. This ain't no half-hearted...

Continue Reading
Florida 500 Honors Influential Health Leaders of 2026

Updated Category News Views 56

Florida 500: Recognizing Impactful Leaders When it comes to shaking up the healthcare scene in Florida, John Couris and his crew are hardly treading water. Once again, Couris is rubbing elbows with the state's influential set, nabbing a spot on Florida Trend's 2026 "Florida 500" list. If you don't know, that's six years in a row. Those who've walked the grueling paths in...

Continue Reading
Nikon Unveils Game-Changing Zoom Lens for Pros

Updated Category News Views 35

Nikon Raises the Bar with New Pro Zoom Lens Well, Nikon's done it again, folks. They've dropped the NIKKOR Z 120-300mm f/2.8 TC VR S lens, and it looks like they're giving photographers something to drool over. Now, before you start rolling your eyes, this isn't just another shiny gadget. This bad boy is lighter and faster than anything Nikon's thrown at us before, and it...

Continue Reading
InventHelp's BLU MESH: A Breath of Fresh and Bug-Free Air

Updated Category News Views 16

Breathing Fresh Air Without the Buzz Here's a fresh spin on driving with the windows down: avoiding bug invasions. We’ve all experienced it—the unexpected slap on the arm or that annoying buzz in your ear just as you're drifting into a long podcast. Thanks to an inventor from East Stroudsburg, Pa., there's an idea on the table for a vehicular add-on that might just...

Continue Reading

Top 5 Most Recently Viewed Articles

US Treasury Bonds React to Strong Labor Market Signals

Updated Category News Views 151

US Treasury Bonds Experience Decline Amid Labor Market News The recent performance of US Treasury bonds has shown a considerable decrease, reflecting market adjustments to expectations surrounding Federal Reserve interest rate cuts. The decline follows indications of a strong labor market, which have led traders to revise their forecasts for the timing of potential rate...

Continue Reading
Why Estate Planning Belongs in a Long Term Investment Strategy

Updated Category Personal Finance Views 35

Investing often focuses on building wealth, achieving financial independence, and creating greater future security, but protecting what you've already accumulated is equally important. Investors who want to understand how wills, trusts, probate, and other estate planning tools can support the management and transfer of their assets can explore the estate planning services...

Continue Reading
Examining the Executive Authority in CPSC Dismissals

Updated Category News Views 254

NCLA Challenges District Court Ruling on Presidential Authority The New Civil Liberties Alliance (NCLA) has taken a significant legal stand regarding the powers of the President, submitting an amicus curiae brief in a case concerning the removal of Consumer Product Safety Commission (CPSC) commissioners. This case, Boyle v. Trump, seeks to overturn a decision made by a...

Continue Reading
Sanoma Corporation's Recent Share Repurchase Highlights

Updated Category News Views 124

Understanding Sanoma Corporation's Share Buyback Strategy Sanoma Corporation is making headlines with its recent share repurchase program, which reflects a strong commitment to enhancing shareholder value. The initiative is not just a routine financial maneuver; it’s a strategic decision aimed at reinforcing investor confidence and optimizing the company’s capital...

Continue Reading
Loomis Reports Strong Q1 Growth and Operational Efficiency

Updated Category News Views 202

Solid Start to the Year Loomis experienced a promising beginning to the fiscal year, boasting an organic revenue growth of 4.4 percent in the opening quarter. The performance across various segments, including the USA, Europe, and Latin America, showed a remarkable positive trend. Particularly, the International business line stood out, contributing significantly to this...

Continue Reading